ClinConnect ClinConnect Logo
Search / Trial NCT06760637

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

Launched by PFIZER · Jan 3, 2025

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Locally Advanced Or Metastatic Breast Cancer Estrogen Receptor Positive [Er(+)] Progesterone Receptor Positive [Pr(+)] Hormone Receptor Positive [Hr(+)] Human Epidermal Growth Factor Receptor 2 Negative [Her2( )] Er(+)/Her2( ) Pr(+)/Her2( ) Hr(+)/Her2( ) Advanced Breast Cancer Breast Tumor Breast Cancer Palbociclib Abemaciclib Ribociclib Partial Response+ (Pr+) Metastatic Breast Cancer Hormone Therapy Hormone Positive Breast Cancer Recurrent Breast Cancer Hr+ Her2 Negative Relapse Recurrent First Line Treatment Left Sided Breast Cancer Left Sided Breast Cancer Right Sided Breast Cancer Right Sided Breast Cancer Unilateral Breast Cancer Cancer Of The Breast Cdk4i Cdk4/6i Bilateral Breast Cancer

ClinConnect Summary

This clinical trial is studying a new treatment called PF-07220060, given alongside letrozole, for adults with a specific type of breast cancer known as HR-positive HER2-negative breast cancer. This trial aims to find out how safe and effective this combination is compared to other approved treatments that also include letrozole. Participants in the study will include adults who have locally advanced or metastatic breast cancer, which means the cancer has spread beyond its original location and cannot be removed through surgery or radiation. Importantly, eligible participants have not received any previous treatments for their advanced cancer.

If you join this study, you will be randomly assigned to receive either the new treatment (PF-07220060 with letrozole) or another approved treatment with letrozole. Throughout the trial, the study team will monitor your health during regular check-ups at the clinic to see how well the treatment is working. To be eligible, participants need to have confirmed breast cancer that has spread, and their cancer must test positive for hormone receptors (which help it grow) but negative for HER2 (a specific protein). However, some individuals may not qualify if they have had certain previous treatments or specific health issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Histological confirmation of breast cancer with evidence of locally advanced or metastatic disease, which is not amenable to surgical resection or radiation therapy with curative intent.
  • Documented estrogen receptor (ER) and/or progesterone receptor (PR)-positive tumor
  • Documented HER2-negative tumor
  • Previously untreated with any systemic anticancer therapy for their locally advanced or metastatic disease.
  • Measurable disease or non-measurable bone only disease as defined by RECIST version 1.1
  • Exclusion Criteria:
  • In visceral crisis at risk of immediately life-threatening complications in the short term.
  • Current or past history of central nervous system metastases.
  • Have received prior (neo)adjuvant endocrine therapy (ET) and had recurrence during or within 12 months after the last dose of ET.
  • Have received prior (neo)adjuvant CDK4/6i and had recurrence during or within 12 months after the last dose of CDK4/6i.
  • Inadequate renal function, hepatic dysfunction, or hematologic abnormalities.

About Pfizer

Pfizer Inc. is a global leader in biopharmaceutical innovation, dedicated to discovering, developing, and delivering advanced therapies that enhance patient outcomes across a wide range of medical conditions. With a rich history of scientific research and a commitment to quality, Pfizer focuses on areas such as oncology, immunology, cardiology, and rare diseases. The company leverages cutting-edge technology and collaborates with healthcare professionals, regulatory bodies, and academic institutions to conduct rigorous clinical trials that ensure the safety and efficacy of its products. Pfizer's mission is to bring breakthroughs that change patients' lives, exemplifying its commitment to health and wellness worldwide.

Locations

Boston, Massachusetts, United States

Boston, Massachusetts, United States

Madrid, , Spain

Miami Beach, Florida, United States

Portland, Oregon, United States

Malaga, , Spain

Boise, Idaho, United States

Portland, Oregon, United States

Frankston, Victoria, Australia

Boston, Massachusetts, United States

Orlando, Florida, United States

Washington, District Of Columbia, United States

Miami Beach, Florida, United States

Los Angeles, California, United States

Woolloongabba, Queensland, Australia

Kansas City, Missouri, United States

Reno, Nevada, United States

Uppsala, , Sweden

Boca Raton, Florida, United States

Parkville, Victoria, Australia

Taipei, , Taiwan

Mumbai, Maharashtra, India

Barcelona, , Spain

Elche, Alicante, Spain

Sapporo, Hokkaido, Japan

Sendai, Miyagi, Japan

Chuo Ku, Tokyo, Japan

Okayama, , Japan

Nagoya, Aichi, Japan

Taichung, , Taiwan

Tainan, , Taiwan

Sevilla, , Spain

Osaka, , Japan

Suita, Osaka, Japan

Taipei, , Taiwan

Melbourne, Victoria, Australia

Praha, , Czechia

Prague, , Czechia

Sakyo Ku, Kyoto, Japan

Chiba, , Japan

Bunkyo Ku, Tokyo, Japan

Barcelona, , Spain

Bayonne, , France

Manchester, , United Kingdom

Guangzhou, Guangdong, China

Nagoya, Aichi, Japan

Chur, , Switzerland

Olten, , Switzerland

Winterthur, , Switzerland

Changchun, Jilin, China

Nagoya, Aichi, Japan

Taoyuan, , Taiwan

Incheon, , Korea, Republic Of

Beijing, Beijing, China

Shenyang, Liaoning, China

Toronto, Ontario, Canada

Fukuoka, , Japan

Koto Ku, Tokyo, Japan

Pune, Maharashtra, India

Xi'an, Shaanxi, China

Taipei, , Taiwan

Seoul, Songpa Gu, Korea, Republic Of

Baden, , Switzerland

Foshan, Guangdong, China

Milano, , Italy

Pasadena, California, United States

Leuven, Vlaams Brabant, Belgium

Skokie, Illinois, United States

Los Angeles, California, United States

Changsha, Hunan, China

Seoul, , Korea, Republic Of

Hangzhou, Zhejiang, China

Stockholm, , Sweden

Beijing, Beijing, China

Créteil, , France

Chandler, Arizona, United States

Springdale, Arkansas, United States

Granada, , Spain

Savannah, Georgia, United States

West Hills, California, United States

Surat, Gujarat, India

Linhai, Zhejiang, China

Budapest, , Hungary

Yokohama, Kanagawa, Japan

Osaka, , Japan

Hiroshima, , Japan

Kumamoto, , Japan

Tel Aviv, , Israel

Seoul, , Korea, Republic Of

Otwock, , Poland

Taipei, , Taiwan

Bozeman, Montana, United States

Madrid, , Spain

Hamburg, , Germany

Glendale, Arizona, United States

Istanbul, , Turkey

Gothenburg, , Sweden

Jerusalem, Yerushalayim, Israel

Beijing, Beijing, China

Orange City, Florida, United States

Pune, Maharashtra, India

Newport Beach, California, United States

Layton, Utah, United States

Salt Lake City, Utah, United States

West Jordan, Utah, United States

Turku, Varsinais Suomi, Finland

Los Angeles, California, United States

Fredericton, New Brunswick, Canada

Burgas, , Bulgaria

Gurugram, Haryana, India

Tyler, Texas, United States

Firenze, Toscana, Italy

Gent, Oost Vlaanderen, Belgium

Plovdiv, , Bulgaria

Portland, Oregon, United States

Portland, Oregon, United States

Ankara, , Turkey

La Roche Sur Yon, , France

Dublin, , Ireland

Orlando, Florida, United States

Rogers, Arkansas, United States

Copenhagen, Hovedstaden, Denmark

Västerås, , Sweden

Newton, Massachusetts, United States

New Delhi, Delhi, India

Reno, Nevada, United States

Salamanca, , Spain

Aarhus, Midtjylland, Denmark

Shinjuku Ku, Tokyo, Japan

West Valley City, Utah, United States

Bordeaux, Aquitaine, France

Sofia, , Bulgaria

Shinagawa, Tokyo, Japan

Dublin, , Ireland

Nashik, Maharashtra, India

Douglas, Queensland, Australia

Novara, , Italy

Gilly, Hainaut, Belgium

Fayetteville, Arkansas, United States

Aalborg, Nordjylland, Denmark

Tampere, Pirkanmaa, Finland

Thane, Maharashtra, India

Uppsala, , Sweden

Bountiful, Utah, United States

Ogden, Utah, United States

Provo, Utah, United States

Rouen, Seine Maritime, France

Vaasa, Pohjanmaa, Finland

Angers Cedex 02, Maine Et Loire, France

Haifa, Hatsafon, Israel

Ramat Gan, Hamerkaz, Israel

Shinjuku City, Tokyo, Japan

Montpellier, Languedoc Roussillon, France

Aviano, Friuli Venezia Giulia, Italy

Barcelona, Barcelona [Barcelona], Spain

Diyarbakir, , Turkey

Istanbul, , Turkey

Wuhan, Hubei, China

Ankara, , Turkey

La Roche Sur Yon, Vendée, France

Petah Tikva, Hamerkaz, Israel

Tel Aviv, Tell Abīb, Israel

Saint Herblain, Loire Atlantique, France

Koblenz, Rheinland Pfalz, Germany

Helsinki, Uusimaa, Finland

Dresden, Sachsen, Germany

Gävle, , Sweden

Malaga, Málaga, Spain

Altamonte Springs, Florida, United States

Praha, Praha 5, Czechia

Rome, Roma, Italy

Kraków, , Poland

Haskovo, , Bulgaria

Ankara, , Turkey

Phoenix, Arizona, United States

Hinsdale, Illinois, United States

Shumen, , Bulgaria

Meldola, Emilia Romagna, Italy

Aarau, Aargau, Switzerland

Frauenfeld, Thurgau, Switzerland

Los Angeles, California, United States

Minneapolis, Minnesota, United States

Jerez De La Frontera, , Spain

Gabrovo, , Bulgaria

Sofia, , Bulgaria

Gothenburg, , Sweden

Otashi, Gunma, Japan

Västerås, , Sweden

Bern, Berne, Switzerland

Ankara, , Turkey

Dalian, Liaoning, China

Kolkata, West Bengal, India

Nanjing, Jiangsu, China

Kraków, Małopolskie, Poland

Evanston, Illinois, United States

Skokie, Illinois, United States

Soenderborg, Syddanmark, Denmark

Sofia, Sofia (Stolitsa), Bulgaria

Istanbul, , Turkey

Eger, Heves, Hungary

London, London, City Of, United Kingdom

Naperville, Illinois, United States

London, Hammersmith And Fulham, United Kingdom

Marousi, , Greece

Golden, Colorado, United States

Rennes, Ille Et Vilaine, France

Gilbert, Arizona, United States

Mesa, Arizona, United States

Scottsdale, Arizona, United States

Bangalore, Karnataka, India

Dresden, , Germany

Skórzewo, Wielkopolskie, Poland

Komarno, Nitriansky Kraj, Slovakia

Banka, Trnavský Kraj, Slovakia

Denver, Colorado, United States

Los Alamitos, California, United States

Baltimore, Maryland, United States

Zhu Bei City, , Taiwan

Aalst, , Belgium

New Lenox, Illinois, United States

Annapolis, Maryland, United States

Esbjerg, Syddanmark, Denmark

Torrance, California, United States

Coon Rapids, Minnesota, United States

Saint Paul, Minnesota, United States

Altamonte Springs, Florida, United States

Altamonte Springs, Florida, United States

Aventura, Florida, United States

Orlando, Florida, United States

Elmhurst, Illinois, United States

Portland, Oregon, United States

Portland, Oregon, United States

Tyler, Texas, United States

Los Alamitos, California, United States

Golden, Colorado, United States

Grand Junction, Colorado, United States

Grand Junction, Colorado, United States

Grand Junction, Colorado, United States

Capel Sound, Victoria, Australia

Marousi, Attikí, Greece

Hyderabad, Telangana, India

łódź, łódzkie, Poland

Jönköping, , Sweden

Sundsvall, , Sweden

Istanbul, İ̇stanbul, Turkey

Kansas City, Missouri, United States

Gangnam Gu, , Korea, Republic Of

Bilbo, , Spain

Athens, , Greece

Kraków, , Poland

Sakarya, , Turkey

London, , United Kingdom

Zhu Bei City, Hsinchu, Taiwan

Banka, , Slovakia

Gävle, , Sweden

Newport Beach, California, United States

Denver, Colorado, United States

Boise, Idaho, United States

Fruitland, Idaho, United States

Meridian, Idaho, United States

Meridian, Idaho, United States

Nampa, Idaho, United States

Murray, Utah, United States

Orem, Utah, United States

Pleasant Grove, Utah, United States

Nový Jičín, , Czechia

αθήνα, , Greece

Athens, , Greece

Dublin, , Ireland

łódź, , Poland

Michalovce, , Slovakia

Hospitalet, , Spain

Stockholm, , Sweden

Münsterlingen, , Switzerland

Patients applied

0 patients applied

Trial Officials

Pfizer CT.gov Call Center

Study Director

Pfizer

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported